@cardiacinterv

Stay current: Follow Cardiac Interventions Today on Twitter @cardiacinterv

News

 

New Guidelines Call for 19% More AF Patients to be Treated With Anticoagulants

March 2, 2015 -- Based on an analysis from the Duke Clinical Research Institute (DCRI), new multisociety guidelines advise that nearly all women and people over 65 years of ag…

EVERBIO II Compares Bioresorbable Vascular Scaffold to New-Generation Drug-Eluting Stents

March 2, 2015 -- Findings from the EVERBIO II study comparing the performance of a bioresorbable vascular scaffold (BVS) with that of everolimus-eluting stents (EES) and bioli…

Published ZEUS Findings Support Medtronic’s Endeavor Sprint ZES in Uncertain DES Candidates

March 2, 2015 -- Investigators in the ZEUS study concluded that using the Endeavor Sprint stent (Medtronic plc) combined with an abbreviated, tailored dual-antiplatelet t…

Cardinal Health to Acquire Cordis

March 2, 2015 -- Cardinal Health announced plans to acquire Johnson & Johnson’s Cordis business for $1.944 billion in cash. The transaction, which is expected to be …

FDA Approves Interim Analysis of Pivotal Trial for Sunshine Heart’s C-Pulse System

February 25, 2015 -- Sunshine Heart, Inc. announced it has received unconditional approval from the US Food and Drug Administration (FDA) to conduct an interim analysis of COU…

Gore REDUCE Clinical Study Completes Enrollment

February 24, 2015 -- Gore & Associates announced completion of enrollment for the Gore REDUCE clinical study, a prospective, randomized, multicenter, multination…

FDA Clears Pie Medical Imaging’s CAAS A-Valve System for Measuring Aortic Regurgitation Based on X-Ray Angiography

February 23, 2015 -- Pie Medical Imaging BV announced that it received 510(k) clearance from the US Food and Drug Administration for the company’s CAAS A-Valve product, …

Invention and Intellectual Property

Protecting Your Inventions, From Idea to Marketplace

The first step in bringing your medical device to market is to understand who owns the rights to your invention.

Beginning the Patent Process

The second step in bringing your medical device to market is to understand whether you can protect your invention.

Evaluating Freedom to Operate

The third step in bringing your medical device to market is to understand whether you can practice your invention.

Featured Center

 

CTOs

 

2015 Buyer’s Guide

 

This Buyer’s Guide offers a searchable, comprehensive listing of the FDA-approved interventional devices available in the United States.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007, with its launch issue focusing on the state of coronary drug-eluting stent use. Each edition will cover a variety of topics in a flexible format that includes articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's cardiology practices.

Website Design by Sides Media